SARS‐CoV‐2 spike trimer vaccine expressed in Nicotiana benthamiana adjuvanted with Alum elicits protective immune responses in mice

The ongoing coronavirus disease 2019 (COVID‐19) pandemic has spurred rapid development of vaccines as part of the public health response. However, the general strategy used to construct recombinant trimeric severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) spike (S) proteins in mammalian...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Shi‐Jian, Kim, Heeyeon, Jang, Eun Young, Jeon, Hyungmin, Diao, Hai‐Ping, Khan, Md Rezaul Islam, Lee, Mi‐Seon, Lee, Young Jae, Nam, Jeong‐hyun, Kim, Seong‐Ryeol, Kim, Young‐Jin, Sohn, Eun‐Ju, Hwang, Inhwan, Choi, Jang‐Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538723/
https://www.ncbi.nlm.nih.gov/pubmed/36062974
http://dx.doi.org/10.1111/pbi.13908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538723/
https://www.ncbi.nlm.nih.gov/pubmed/36062974
http://dx.doi.org/10.1111/pbi.13908

Ejemplares similares